Mark Levis, MD, PhD from The Johns Hopkins University, Baltimore, MD discusses a common question that acute myeloid leukemia (AML) patients ask on their first visit, “how did I get this?”. Today there is a much better understanding of AML and often its cause cannot be pinpointed to a patient’s actions but rather is caused by the natural increase of mutations with age. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates